- docs/build-plans/00-signal-reactivation-plan.md: umbrella re-activation plan
(two-currency logic, critical path, Week1/Week2/backlog sequence with
owners+gates, labABLE-vs-Gaboro call, compliance guardrail, 2026-07-06 findings).
- docs/compliance/fda-cds-exemption-memo-DRAFT.md: attorney-review draft (Fable).
Primary position = Signal is administrative/billing software outside the FD&C
201(h) device definition; CDS-exemption kept as the secondary argument. Citations
grounded against current FDA sources (CDS guidance updated 2026-01-29).
Flags: internal 2026-06-04 whitepaper overstates the CDS claim; attorney of
record unconfirmed (Bittinger/Nixon vs Clyde Mathes).
Co-Authored-By: Claude Opus 4.8 (1M context) <noreply@anthropic.com>
